108 related articles for article (PubMed ID: 7523030)
1. Vitreal insulin-like growth factor binding proteins (IGFBPs) are increased in human and animal diabetics.
Waldbillig RJ; Jones BE; Schoen TJ; Moshayedi P; Heidersbach S; Bitar MS; van Kuijk FJ; de Juan E; Kador P; Chader GJ
Curr Eye Res; 1994 Jul; 13(7):539-46. PubMed ID: 7523030
[TBL] [Abstract][Full Text] [Related]
2. Distribution of IGF-I and -II, IGF binding proteins (IGFBPs) and IGFBP mRNA in ocular fluids and tissues: potential sites of synthesis of IGFBPs in aqueous and vitreous.
Arnold DR; Moshayedi P; Schoen TJ; Jones BE; Chader GJ; Waldbillig RJ
Exp Eye Res; 1993 May; 56(5):555-65. PubMed ID: 7684697
[TBL] [Abstract][Full Text] [Related]
3. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.
Meyer-Schwickerath R; Pfeiffer A; Blum WF; Freyberger H; Klein M; Lösche C; Röllmann R; Schatz H
J Clin Invest; 1993 Dec; 92(6):2620-5. PubMed ID: 7504689
[TBL] [Abstract][Full Text] [Related]
4. Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors.
McCarthy TL; Casinghino S; Centrella M; Canalis E
J Cell Physiol; 1994 Jul; 160(1):163-75. PubMed ID: 7517403
[TBL] [Abstract][Full Text] [Related]
5. Free insulin-like growth factor 1 in the vitreous fluid of diabetic patients with proliferative diabetic retinopathy: a case-control study.
Simó R; Hernández C; Segura RM; García-Arumí J; Sararols L; Burgos R; Cantón A; Mesa J
Clin Sci (Lond); 2003 Mar; 104(3):223-30. PubMed ID: 12605576
[TBL] [Abstract][Full Text] [Related]
6. Tissue-specific regulation of insulin-like growth factors and insulin-like growth factor binding proteins in male diabetic rats in vivo and in vitro.
Han HJ; Kang CW; Park SH
Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1172-9. PubMed ID: 17184497
[TBL] [Abstract][Full Text] [Related]
7. Local synthesis and developmental regulation of avian vitreal insulin-like growth factor-binding proteins: a model for independent regulation in extravascular and vascular compartments.
Schoen TJ; Beebe DC; Clemmons DR; Chader GJ; Waldbillig RJ
Endocrinology; 1992 Dec; 131(6):2846-54. PubMed ID: 1280206
[TBL] [Abstract][Full Text] [Related]
8. Expression of the IGF system in normal and diabetic transgenic (mRen-2)27 rat eye.
Bergman PB; Moravski CJ; Edmondson SR; Russo VC; Bach LA; Wilkinson-Berka JL; Werther GA
Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2708-15. PubMed ID: 16043842
[TBL] [Abstract][Full Text] [Related]
9. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?
Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K
Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor binding proteins modulate Müller cell responses to insulin-like growth factors.
King JL; Guidry C
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2848-55. PubMed ID: 15277512
[TBL] [Abstract][Full Text] [Related]
11. Diabetic retinopathy is associated with decreased serum levels of free IGF-I and changes of IGF-binding proteins.
Feldmann B; Jehle PM; Mohan S; Lang GE; Lang GK; Brueckel J; Boehm BO
Growth Horm IGF Res; 2000 Feb; 10(1):53-9. PubMed ID: 10753593
[TBL] [Abstract][Full Text] [Related]
12. Pre- and post-translational regulation of renal insulin-like growth factor binding protein-1 in insulin-deficient diabetes.
Kaufman CR; Catanese VM
J Investig Med; 1995 Apr; 43(2):178-86. PubMed ID: 7537614
[TBL] [Abstract][Full Text] [Related]
13. Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study.
Burgos R; Mateo C; Cantón A; Hernández C; Mesa J; Simó R
Diabetes Care; 2000 Jan; 23(1):80-3. PubMed ID: 10857973
[TBL] [Abstract][Full Text] [Related]
14. The changes of IGF binding proteins after rhGH administration to patients totally dependent on parenteral nutrition.
Justová V; Lacinová Z; Melenovský V; Marek J; Holly JM; Hass T
Growth Horm IGF Res; 2001 Dec; 11(6):407-15. PubMed ID: 11914029
[TBL] [Abstract][Full Text] [Related]
15. [Growth hormone, insulin-like growth factor and insulin-like growth factor binding protein in young type I diabetes patients with the onset of diabetic angiopathy].
Peczyńska J; Urban M; Głowińska B; Urban B
Pol Merkur Lekarski; 2003 Apr; 14(82):336-9. PubMed ID: 12868196
[TBL] [Abstract][Full Text] [Related]
16. Systemic levels contribute significantly to increased intraocular IGF-I, IGF-II and IGF-BP3 [correction of IFG-BP3] in proliferative diabetic retinopathy.
Spranger J; Bühnen J; Jansen V; Krieg M; Meyer-Schwickerath R; Blum WF; Schatz H; Pfeiffer AF
Horm Metab Res; 2000 May; 32(5):196-200. PubMed ID: 10871161
[TBL] [Abstract][Full Text] [Related]
17. Effects of glucocorticoids on circulating levels and hepatic expression of insulin-like growth factor (IGF)-binding proteins and IGF-I in the adrenalectomized streptozotocin-diabetic rat.
Unterman TG; Jentel JJ; Oehler DT; Lacson RG; Hofert JF
Endocrinology; 1993 Dec; 133(6):2531-9. PubMed ID: 7694841
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor binding protein-1 levels in diabetic proliferative retinopathy.
Hopkins KD; Brart DO; Russell-Jones DL; Chignell AH; Sönksen PH
Horm Metab Res; 1993 Jun; 25(6):331-2. PubMed ID: 7688338
[No Abstract] [Full Text] [Related]
19. Specific alterations of the insulin-like growth factor I system in the cerebellum of diabetic rats.
Busiguina S; Chowen JA; Argente J; Torres-Aleman I
Endocrinology; 1996 Nov; 137(11):4980-7. PubMed ID: 8895371
[TBL] [Abstract][Full Text] [Related]
20. Growth factor alterations in advanced diabetic retinopathy: a possible role of blood retina barrier breakdown.
Pfeiffer A; Spranger J; Meyer-Schwickerath R; Schatz H
Diabetes; 1997 Sep; 46 Suppl 2():S26-30. PubMed ID: 9285495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
